Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). LifeTech Scientific's share price for the quarter that ended in Dec. 2025 was $0.2335. LifeTech Scientific's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 4,400.8 Mil. Therefore, LifeTech Scientific's market cap for the quarter that ended in Dec. 2025 was $1,027.6 Mil.
LifeTech Scientific's quarterly market cap
increased
from Dec. 2024 ($1,027.3 Mil) to Jun. 2025 ($1,027.6 Mil) but then
stayed the same
from Jun. 2025 ($1,027.6 Mil) to Dec. 2025 ($1,027.6 Mil).
LifeTech Scientific's annual market cap
declined
from Dec. 2023 ($1,495.8 Mil) to Dec. 2024 ($1,027.3 Mil) but then
increased
from Dec. 2024 ($1,027.3 Mil) to Dec. 2025 ($1,027.6 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. LifeTech Scientific's Enterprise Value for Today is $623.7 Mil.
LifeTech Scientific (OTCPK:LFTSF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
LifeTech Scientific Market Cap Related Terms
LifeTech Scientific Market Cap Historical Data
* Premium members only.
The historical data trend for LifeTech Scientific's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, LifeTech Scientific's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeTech Scientific Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's Market Cap distribution charts can be found below:
* The bar in red indicates where LifeTech Scientific's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
LifeTech Scientific's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeTech Scientific (LFTSF) has a Market Cap of $796.9 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on LifeTech Scientific and its competitors. According to the industry distribution chart, LifeTech Scientific ranks #207 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 23.9%.
Is LifeTech Scientific's Market Cap too high?
LifeTech Scientific's current Market Cap is $796.9 Mil. The Medical Devices & Instruments industry median Market Cap is 120.18. LifeTech Scientific's value of $796.9 Mil is 563.1% above this industry median. Based on the distribution chart, LifeTech Scientific ranks #207 out of 867 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, LifeTech Scientific has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does LifeTech Scientific's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, LifeTech Scientific ranks #207 out of 867 companies for Market Cap. This places LifeTech Scientific in the top 24% of its industry — outperforming the majority of peers. The industry median Market Cap is 120.18. LifeTech Scientific's value of $796.9 Mil is 563.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 120.18, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeTech Scientific's current Market Cap of $796.9 Mil is 563.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on LifeTech Scientific and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 120.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeTech Scientific's current Market Cap is $796.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeTech Scientific stock overvalued right now?
LifeTech Scientific (LFTSF) has a current Market Cap of $796.9 Mil. The stock's GF Value™ is $0.36, compared to a current price of $0.23 — trading 35.1% below its estimated fair value. The current Market Cap is $796.9 Mil and 563.1% above the Medical Devices & Instruments industry median of 120.18. LifeTech Scientific's overall GF Score™ is 96/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For LifeTech Scientific (LFTSF), the current Market Cap is $796.9 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeTech Scientific (LFTSF) Overvalued in 2026?
Based on GuruFocus' analysis, LifeTech Scientific stock appears to be undervalued.
The current stock price of $0.23 is trading 35.1% below its estimated GF Value™ of $0.36.
Key valuation signals for LFTSF:
Market Cap: $796.9 Mil
GF Value™: $0.36 vs. price of $0.23 (35.1% below fair value)
Industry Position: 563.1% above the Medical Devices & Instruments median (#207 of 867)
No single metric tells the full story. See the LFTSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeTech Scientific Corp develops and manufactures also responsible for marketing of minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: the Structural heart diseases business, the Peripheral vascular diseases business, and the Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral Vascular Diseases business segment. Geographically, it derives a majority of its revenue from Mainland China, and it also has its presence in Europe, Asia, excluding mainland China and India, India, South America, Africa, and Others.
96GF Score
Get the complete analysis for LFTSF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFTSF has been successfully added to your 
